Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts on Utility of clonoSEQ® in MRD Testing in Blood Cancer Patients at the 63rd ASH Annual Meeting
SEATTLE, Dec. 02, 2021 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage…
BOMESI Foundation Opens Fifth Accelerator Cohort For Diverse-Owned Media Publishers And Creators
Ynvisible Advances Commercial Program with Sapphiros, Announces CFO Appointment and Adoption of Semi-Annual Financial Reporting
Airwheel SE3SX AI Wheel Luxury Suitcase Wins 2026 WGA for Smart Electric Riding Carry-On Hand Luggage
Syntheia Signs Definitive Agreement for Sale of Call Center Assets and Announces Shares for Debt Transaction